Abstract:Abstract Introduction The risk of cardiovascular disease increases during the menopausal transition. In addition to estradiol decline during the transition, there is increased sleep fragmentation due to hot flashes, without reduced total sleep time. We examined the impact of sleep fragmentation and estradiol decline on cardiometabolic outcomes in an experimental menopause model implemented in premenopausal women. Methods We studied 38 healthy premenopausal women (mean age [±SD] 29.7±6.7 years) in a 5-night inpatient study under eucaloric conditions, once in the mid-to-late follicular phase (high estradiol) and again after gonadotropin-releasing hormone agonist-induced estradiol suppression in a subset (n=27). Each inpatient study involved 2 nights of unfragmented sleep followed by 3 nights of experimentally sound-induced sleep fragmentation to achieve ~1 h of wake after sleep-onset, without reducing total sleep time. Cardiometabolic endpoints (serum and vitals) were collected while fasted within 1 h of waking each morning. Values were normalized relative to each individual’s baseline (estrogenized, unfragmented sleep) and then compared between conditions using generalized linear mixed models. Results Sleep fragmentation across both estradiol states combined significantly lowered self-rated satiety by 13% (p=0.048), and increased hunger by 30%, although this difference did not reach significance (p=0.25), and leptin and acylated ghrelin levels were unchanged (both, p≥0.13). Sleep fragmentation significantly reduced triglycerides by 7% (p< 0.01) and increased heart rate (HR) by 6% (p< 0.01). All other cardiometabolic endpoints were unchanged by sleep fragmentation (p≥0.22). E2 suppression lowered self-rated satiety by 5% and increased hunger by 28%, but neither of these were significant (both, p≥0.28), and significantly lowered leptin levels by 6% (p=0.001), and increased ghrelin by 7% although this did not reach significance (p=0.13). Estradiol suppression across both sleep conditions combined significantly increased triglycerides, total cholesterol and HDL-C by 5% to 8% (all, p< 0.01) but not LDL-C (p=0.18). Estradiol suppression significantly reduced HR by 4% (p< 0.01) and trended to increase diastolic blood pressure by 3% (p=0.06), with no change in systolic blood pressure (p=0.16). Conclusion Findings support independent contributions of estradiol decline and sleep fragmentation during the menopause transition toward positive energy balance and adverse changes in cardiovascular disease risk factors. Support (if any) NIH R01AG053838

0020 Heart Rate Variability Changes During Sleep in Postmenopausal Women

Dampened circadian amplitude of EEG power in women after menopause

Blunted cardiac autonomic dynamics to active standing test in postmenopausal women

0289 Sleep Fragmentation and Estradiol Suppression Effects on Cardiometabolic Health in Women: An Experimental Model

Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women's Health Initiative study

Role of age, menopausal status, and symptoms in midlife women: Examination of sleep patterns and rest-activity circadian rhythms

Sex‐specific changes in sleep quality with aging: Insights from wearable device analysis

The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis

1002 Heart Rate Variability During Sleep and Future Risk of Parkinson’s Disease in Community-dwelling Older Men

Regulation of exercise on heart rate variability in perimenopausal and postmenopausal women

Protein Biomarkers of Early Menopause and Incident Cardiovascular Disease

Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles

Evolution of sleep-disordered breathing and blood pressure during menopausal transition

What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy

Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia.

Abstract P3119: Identifying The Windows Of Cardiac Risk And Opportunity In Menopause

Relationship between sleep quality and cardiovascular disease risk in Chinese post-menopausal women

Vasomotor symptoms and cardiovascular events in postmenopausal women

Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study

Morning tiredness and insomnia symptoms are associated with increased blood pressure in midlife women

Menopause transition and cardiovascular disease risk